Updated:
ConcertAI
ConcertAI orchestrates clinical expertise, real-world data, and applied AI to deliver practical intelligence for the demands of oncology and other complex...
Overview
ConcertAI orchestrates clinical expertise, real-world data, and applied AI to deliver practical intelligence for the demands of oncology and other complex diseases.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
Cambridge, MA, United States
Additional offices
Durham, NC · Frankfurt, Germany · Tokyo, Japan
Sector focus
Frequently asked questions
What is the relationship between ConcertAI and TeraRecon?
TeraRecon operates as a ConcertAI subsidiary, providing FDA-cleared advanced visualization and AI-driven imaging software. It maintains its own headquarters in Durham, North Carolina, and international offices in Frankfurt and Tokyo, functioning as the imaging-software arm of ConcertAI's broader oncology data platform.
Which therapeutic areas does ConcertAI cover, and are there notable exclusions?
Public materials commit the firm to oncology and other complex diseases. Oncology remains the most visibly developed vertical, supported by real-world data assets and investigator-site tools. No explicit sector avoidances are published, though the commercial focus stays tightly coupled to cancer-research workflows.
How does ConcertAI generate revenue?
ConcertAI licenses real-world data, AI models, and workflow software to pharmaceutical sponsors and clinical research organizations. Its TeraRecon subsidiary sells imaging-software subscriptions and associated support services, creating a dual revenue architecture from data plus regulated medical-device software.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: